Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: A single center experience and a review (277 views)
Cancer (ISSN: 0008-543x), 2003 May 15; 97(10): 2453-2461.
Export to BibTeX Export to EndNote
Paper type: Journal Article,
Impact factor: 2.045, 5-year impact factor: 5.445
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-0038370949&partnerID=40&md5=e8b171b1dbb1ff05e361e8a229f5b5c5
Keywords: Avascular Necrosis, Bone Mineral Density, Fibroblast Colony-Forming Unit, Graft Versus Host Disease, Stem Cell Transplantation, Steroid Treatment, Alpha Interferon, Analgesic Agent, Asparaginase, Bleomycin, Busulfan, Carmustine, Chlorambucil, Cyclophosphamide, Cyclosporin, Cytarabine, Daunorubicin, Doxorubicin, Epirubicin, Etoposide, Fludarabine, Hydroxyurea, Idarubicin, Melphalan, Methotrexate, Methylprednisolone, Mitoxantrone, Vincristine, Adult, Autologous Bone Marrow Transplantation, Blood Disease, Cancer Surgery, Cancer Survival, Cell Growth, Colony Forming Unit, Controlled Study, Disease Course, Dual Energy X Ray Absorptiometry, Electromagnetic Radiation, Female, Femur Head, Follow Up, Graft Versus Host Reaction, Human, Human Tissue, In Vitro Study, Long Term Care, Major Clinical Study, Nuclear Magnetic Resonance Imaging, Postoperative Complication, Priority Journal, Prospective Study, Review, Risk Factor, Total Hip Prosthesis, Article, Bone Density, Bone Necrosis, Case Control Study, Disease Free Survival, Italy, Leukemia, Mortality, Pathology, Prevalence, Case-Control Studies, Disease-Free Survival, Osteonecrosis, Prospective Studies, Survivors,
Affiliations:
*** IBB - CNR ***
Dept. of Molecular Endocrinology, Federico II University, Naples, Italy
Division of Hematology, Federico II University, Via S. Pansini 5, 80131 Naples, Italy
Department of Orthopedics, Federico II University, Naples, Italy
Dept. of Biomorphological Sciences, Federico II University, Naples, Italy
References:
Bewick, M., Stewart, P.H., Rudge, C., Farrand, C., McColl, I., Avascular necrosis of bone in patients undergoing renal allotransplantation (1976) Clin Nephrol, 5, pp. 66-7
Hawking, K.M., Avascular necrosis of bone after renal transplant (1976) N Engl J Med, 294, p. 397
Atkinson, K., Cohen, M., Biggs, J., Avascular necrosis of the femoral head secondary to corticosteroid therapy for graft-versus-host disease after marrow transplantation: Effective therapy with hip arthroplasty (1987) Bone Marrow Transplant, 2, pp. 421-426
Mont, M.A., Hungerford, D.S., Non-traumatic avascular necrosis of the femoral head (1995) J BoneJoint Surg [Am], 77, pp. 459-474
Chang, C.C., Greenspan, A., Gershwin, M.E., Osteonecrosis: Current perspectives on pathogenesis and treatment (1993) Semin Arthritis Rheum, 23, pp. 47-69
Mankin, H.J., Nontraumatic necrosis of bone (osteonecrosis) (1992) N Engl J Med, 326, pp. 1473-1479
Vreden, S.G., Hermus, A.R., Van Liessum, P.A., Pieters, G.F., Smals, A.G., Kloppenborg, P.W., Aseptic bone necrosis in patients on glucocorticoid replacement therapy (1991) Neth J Med, 39, pp. 153-157
Sullivan, K.M., Graft versus host disease (1994) Bone Marrow Transplantation, pp. 339-362. , Forman SJ, Blume KG, Thomas ED. Boston: Blackwell Scientific
Tauchmanovà, L., Serio, B., Del Puente, A., Long-lasting bone damage detected by dual energy x-ray absorptiometry, phalangeal osteosonogrammetry and in vitro growth of marrow stromal cells after allogeneic stem cell transplantation (2002) J Clin Endocrinol Metab, 87, pp. 5058-5065
Stulberg, B.N., Editorial comment on fifth international symposium on bone circulation (1997) Clin Orthop, 334, pp. 2-3
Dumont, M., Dunais, S., Taillefer, R., "Doughnut" sign in avascular necrosis of the bone (1983) Clin Nucl Med, 9, pp. 44-47
Enright, H., Haake, R., Weisdor, D., Avascular necrosis of bone: A common serious complication of allogeneic bone marrow transplantation (1990) Am J Med, 89, pp. 733-738
Sociè, G., Selimi, G., Sedel, L., Avascular necrosis of bone after allogeneic bone marrow transplantation: Clinical findings, incidence and risk factors (1994) Br J Haematol, 86, pp. 624-628
Sociè, G., Cahn, J.Y., Carmelo, J., Avascular necrosis of bone after allogeneic bone marrow transplantation: Analysis of risk factors of 4388 patients by the Société Francaise de Greffe de Moëlle (SFGM) (1997) Br J Haematol, 97, pp. 865-870
Fink, J.C., Leisenring, W.M., Sullivan, K.M., Sherrard, D.J., Weiss, N.S., Avascular necrosis following bone marrow transplantation: A case-control study (1998) Bone, 22, pp. 67-71
Mascarin, M., Giavitto, M., Zanazzo, G.A., Avascular necrosis of bone in children undergoing allogeneic bone marrow transplantation (1991) Cancer, 68, pp. 655-659
Wiesmann, A., Pereira, P., Bohm, P., Faul, C., Kanz, L., Einsele, H., Avascular necrosis of bone following allogeneic stem cell transplantation: MR screening and therapeutic options (1998) Bone Marrow Transplant, 22, pp. 565-569
Ebeling, P.R., Thomas, D.M., Erbans, B., Hopper, J.L., Szer, J., Grigg, A., Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation (1999) J Bone Miner Res, 14, pp. 342-350
Mazières, B., Osteonecrosis (1994) Rheumatology, , Klippel JH, Dieppe PA. London: Mosby: 47.1-47.10
Calandriello, B., Grassi, G., Idiopathic osteonecrosis of the femoral head. Epidemiological and aetiological factors (1982) Ital J Orthop Trauma, 8, pp. 9-18
Shane, R., Rivas, M.D.C., Silverberg, S.J., Osteoporosis after cardiac transplant (1993) Am J Med, 94, pp. 257-264
Lee, A.H., Mull, R.L., Keenan, G.F., Osteoporosis and bone morbidity in cardiac transplant recipients (1994) Am J Med, 86, pp. 35-41
Braun, W.E., Richmond, B.J., Protiva, D.A., Gifford, R.W., Straffon, R.A., The incidence and management of osteoporosis, gout, and avascular necrosis in recipients of renal allografts functioning more than 20 years (level 5A) treated with prednisone and azathioprine (1999) Transpl Proc, 31, pp. 1366-1369
Grotz, W., Breitffennnldt, K., Cybulla, M., Immunosuppression and skeletal disorders (2001) Transplant Proc, 33, pp. 992-993
Mori, A., Hashino, S., Kobayashi, S., Avascular necrosis in the femoral head secondary to bone marrow infarction in patient with graft-versus-host disease after unrelated bone marrow transplantation (2001) Ann Hematol, 80, pp. 238-242
Stern, J.M., Sullivan, K.M., Ott, S.M., Bone density loss after allogeneic hematopoietic stem cell transplantation: A prospective study (2001) Biol Blood Marrow Transplant, 7, pp. 257-264
Zizic, T.M., Marcoux, C., Hungerford, D.S., Dansereau, J.V., Stevens, M.B., Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus (1985) Am J Med, 79, pp. 596-604
Gosling, D.C., Sampson, W.F.D., MadLeod, M., Hanby, A.M., Slapek, M., Susceptibiliy of the rabbit and the rat to steroid osteonecrosis: An experimental study (1987) Transplantation, 43, pp. 751-753
Sato, K., Satomi, S., Oguma, S., Relationship between aseptic necrosis of femoral head bone and immunosuppression therapy, especially CsA administration (1993) Nippon Geka Gakkai Zasshi, 94, pp. 832-839
Wagener, P., Schulte, D., Link, H., Kirchner, H., Stoll, M., Polwoda, H., Musculoskeletal manifestations in patients after bone marrow transplantation. Initial clinical rheumatologic observation (1991) Z Rheumatol, 50, pp. 199-203
Torii, Y., Hasegawa, Y., Kubo, T., Osteonecrosis of the femoral head after allogeneic bone marrow transplantation (2001) Clin Orthop, 382, pp. 124-132
Cancer (ISSN: 0008-543x), 2003 May 15; 97(10): 2453-2461.
Export to BibTeX Export to EndNote
Paper type: Journal Article,
Impact factor: 2.045, 5-year impact factor: 5.445
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-0038370949&partnerID=40&md5=e8b171b1dbb1ff05e361e8a229f5b5c5
Keywords: Avascular Necrosis, Bone Mineral Density, Fibroblast Colony-Forming Unit, Graft Versus Host Disease, Stem Cell Transplantation, Steroid Treatment, Alpha Interferon, Analgesic Agent, Asparaginase, Bleomycin, Busulfan, Carmustine, Chlorambucil, Cyclophosphamide, Cyclosporin, Cytarabine, Daunorubicin, Doxorubicin, Epirubicin, Etoposide, Fludarabine, Hydroxyurea, Idarubicin, Melphalan, Methotrexate, Methylprednisolone, Mitoxantrone, Vincristine, Adult, Autologous Bone Marrow Transplantation, Blood Disease, Cancer Surgery, Cancer Survival, Cell Growth, Colony Forming Unit, Controlled Study, Disease Course, Dual Energy X Ray Absorptiometry, Electromagnetic Radiation, Female, Femur Head, Follow Up, Graft Versus Host Reaction, Human, Human Tissue, In Vitro Study, Long Term Care, Major Clinical Study, Nuclear Magnetic Resonance Imaging, Postoperative Complication, Priority Journal, Prospective Study, Review, Risk Factor, Total Hip Prosthesis, Article, Bone Density, Bone Necrosis, Case Control Study, Disease Free Survival, Italy, Leukemia, Mortality, Pathology, Prevalence, Case-Control Studies, Disease-Free Survival, Osteonecrosis, Prospective Studies, Survivors,
Affiliations:
*** IBB - CNR ***
Dept. of Molecular Endocrinology, Federico II University, Naples, Italy
Division of Hematology, Federico II University, Via S. Pansini 5, 80131 Naples, Italy
Department of Orthopedics, Federico II University, Naples, Italy
Dept. of Biomorphological Sciences, Federico II University, Naples, Italy
References:
Bewick, M., Stewart, P.H., Rudge, C., Farrand, C., McColl, I., Avascular necrosis of bone in patients undergoing renal allotransplantation (1976) Clin Nephrol, 5, pp. 66-7
Hawking, K.M., Avascular necrosis of bone after renal transplant (1976) N Engl J Med, 294, p. 397
Atkinson, K., Cohen, M., Biggs, J., Avascular necrosis of the femoral head secondary to corticosteroid therapy for graft-versus-host disease after marrow transplantation: Effective therapy with hip arthroplasty (1987) Bone Marrow Transplant, 2, pp. 421-426
Mont, M.A., Hungerford, D.S., Non-traumatic avascular necrosis of the femoral head (1995) J BoneJoint Surg [Am], 77, pp. 459-474
Chang, C.C., Greenspan, A., Gershwin, M.E., Osteonecrosis: Current perspectives on pathogenesis and treatment (1993) Semin Arthritis Rheum, 23, pp. 47-69
Mankin, H.J., Nontraumatic necrosis of bone (osteonecrosis) (1992) N Engl J Med, 326, pp. 1473-1479
Vreden, S.G., Hermus, A.R., Van Liessum, P.A., Pieters, G.F., Smals, A.G., Kloppenborg, P.W., Aseptic bone necrosis in patients on glucocorticoid replacement therapy (1991) Neth J Med, 39, pp. 153-157
Sullivan, K.M., Graft versus host disease (1994) Bone Marrow Transplantation, pp. 339-362. , Forman SJ, Blume KG, Thomas ED. Boston: Blackwell Scientific
Tauchmanovà, L., Serio, B., Del Puente, A., Long-lasting bone damage detected by dual energy x-ray absorptiometry, phalangeal osteosonogrammetry and in vitro growth of marrow stromal cells after allogeneic stem cell transplantation (2002) J Clin Endocrinol Metab, 87, pp. 5058-5065
Stulberg, B.N., Editorial comment on fifth international symposium on bone circulation (1997) Clin Orthop, 334, pp. 2-3
Dumont, M., Dunais, S., Taillefer, R., "Doughnut" sign in avascular necrosis of the bone (1983) Clin Nucl Med, 9, pp. 44-47
Enright, H., Haake, R., Weisdor, D., Avascular necrosis of bone: A common serious complication of allogeneic bone marrow transplantation (1990) Am J Med, 89, pp. 733-738
Sociè, G., Selimi, G., Sedel, L., Avascular necrosis of bone after allogeneic bone marrow transplantation: Clinical findings, incidence and risk factors (1994) Br J Haematol, 86, pp. 624-628
Sociè, G., Cahn, J.Y., Carmelo, J., Avascular necrosis of bone after allogeneic bone marrow transplantation: Analysis of risk factors of 4388 patients by the Société Francaise de Greffe de Moëlle (SFGM) (1997) Br J Haematol, 97, pp. 865-870
Fink, J.C., Leisenring, W.M., Sullivan, K.M., Sherrard, D.J., Weiss, N.S., Avascular necrosis following bone marrow transplantation: A case-control study (1998) Bone, 22, pp. 67-71
Mascarin, M., Giavitto, M., Zanazzo, G.A., Avascular necrosis of bone in children undergoing allogeneic bone marrow transplantation (1991) Cancer, 68, pp. 655-659
Wiesmann, A., Pereira, P., Bohm, P., Faul, C., Kanz, L., Einsele, H., Avascular necrosis of bone following allogeneic stem cell transplantation: MR screening and therapeutic options (1998) Bone Marrow Transplant, 22, pp. 565-569
Ebeling, P.R., Thomas, D.M., Erbans, B., Hopper, J.L., Szer, J., Grigg, A., Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation (1999) J Bone Miner Res, 14, pp. 342-350
Mazières, B., Osteonecrosis (1994) Rheumatology, , Klippel JH, Dieppe PA. London: Mosby: 47.1-47.10
Calandriello, B., Grassi, G., Idiopathic osteonecrosis of the femoral head. Epidemiological and aetiological factors (1982) Ital J Orthop Trauma, 8, pp. 9-18
Shane, R., Rivas, M.D.C., Silverberg, S.J., Osteoporosis after cardiac transplant (1993) Am J Med, 94, pp. 257-264
Lee, A.H., Mull, R.L., Keenan, G.F., Osteoporosis and bone morbidity in cardiac transplant recipients (1994) Am J Med, 86, pp. 35-41
Braun, W.E., Richmond, B.J., Protiva, D.A., Gifford, R.W., Straffon, R.A., The incidence and management of osteoporosis, gout, and avascular necrosis in recipients of renal allografts functioning more than 20 years (level 5A) treated with prednisone and azathioprine (1999) Transpl Proc, 31, pp. 1366-1369
Grotz, W., Breitffennnldt, K., Cybulla, M., Immunosuppression and skeletal disorders (2001) Transplant Proc, 33, pp. 992-993
Mori, A., Hashino, S., Kobayashi, S., Avascular necrosis in the femoral head secondary to bone marrow infarction in patient with graft-versus-host disease after unrelated bone marrow transplantation (2001) Ann Hematol, 80, pp. 238-242
Stern, J.M., Sullivan, K.M., Ott, S.M., Bone density loss after allogeneic hematopoietic stem cell transplantation: A prospective study (2001) Biol Blood Marrow Transplant, 7, pp. 257-264
Zizic, T.M., Marcoux, C., Hungerford, D.S., Dansereau, J.V., Stevens, M.B., Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus (1985) Am J Med, 79, pp. 596-604
Gosling, D.C., Sampson, W.F.D., MadLeod, M., Hanby, A.M., Slapek, M., Susceptibiliy of the rabbit and the rat to steroid osteonecrosis: An experimental study (1987) Transplantation, 43, pp. 751-753
Sato, K., Satomi, S., Oguma, S., Relationship between aseptic necrosis of femoral head bone and immunosuppression therapy, especially CsA administration (1993) Nippon Geka Gakkai Zasshi, 94, pp. 832-839
Wagener, P., Schulte, D., Link, H., Kirchner, H., Stoll, M., Polwoda, H., Musculoskeletal manifestations in patients after bone marrow transplantation. Initial clinical rheumatologic observation (1991) Z Rheumatol, 50, pp. 199-203
Torii, Y., Hasegawa, Y., Kubo, T., Osteonecrosis of the femoral head after allogeneic bone marrow transplantation (2001) Clin Orthop, 382, pp. 124-132
Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: A single center experience and a review
BACKGROUND. The most debilitating skeletal complication of stem cell transplantation (SCT) is avascular necrosis (AVN). METHODS. Two hundred seven consecutive patients were evaluated prospectively for AVN. They survived disease free for more than 180 days after autologous or allogeneic SCT for hematologic malignancies. The diagnosis of AVN in suspicious cases was confirmed by magnetic resonance imaging. Possible correlations with treatments, bone mineral density (BMD), graft versus host disease (GVHD), and in vitro growth of fibroblast progenitors were investigated. Bone mineral density was evaluated by dual-energy X-ray absorptiometry in 100 transplanted patients, and the in vitro growth of fibroblast progenitors was monitored by a fibroblast colony-forming unit (CFU-F) assay in 30 patients after allogeneic SCT. RESULTS. Twelve patients developed AVN 3-114 months (median, 26 months) following SCT: 10 (10%) after allogeneic SCT and 2 (1.9%) after autologous SCT (P = 0.04). Twenty-five joints were affected by AVN. All patients had femoral head involvement, which was managed with hip replacement in six of them. All but one patient who developed AVN after allogeneic SCT suffered from chronic GVHD (cGVHD). Avascular necrosis occurred 1-4 months after exacerbation or progression of cGVHD. Cumulative dose of steroids was similar in both SCT groups (including steroids given pretransplant for the basic disease), whereas treatment duration was significantly longer in the allogeneic SCT group. Avascular necrosis was related to the decreased number of bone marrow CFU-F colonies in vitro, but not to BMD values. CONCLUSIONS. Avascular necrosis is a skeletal complication that occurs more often after allogeneic than after autologous SCT. Occurrence of AVN symptoms after clinical follow-p of cGVHD suggests that cGVHD requiring long-term steroid therapy is one of the main risk factors for AVN. Avascular necrosis may be facilitated by a severe deficit in the repopulating capacity of bone marrow stromal stem cells after SCT. © 2003 American Cancer Society.
BACKGROUND. The most debilitating skeletal complication of stem cell transplantation (SCT) is avascular necrosis (AVN). METHODS. Two hundred seven consecutive patients were evaluated prospectively for AVN. They survived disease free for more than 180 days after autologous or allogeneic SCT for hematologic malignancies. The diagnosis of AVN in suspicious cases was confirmed by magnetic resonance imaging. Possible correlations with treatments, bone mineral density (BMD), graft versus host disease (GVHD), and in vitro growth of fibroblast progenitors were investigated. Bone mineral density was evaluated by dual-energy X-ray absorptiometry in 100 transplanted patients, and the in vitro growth of fibroblast progenitors was monitored by a fibroblast colony-forming unit (CFU-F) assay in 30 patients after allogeneic SCT. RESULTS. Twelve patients developed AVN 3-114 months (median, 26 months) following SCT: 10 (10%) after allogeneic SCT and 2 (1.9%) after autologous SCT (P = 0.04). Twenty-five joints were affected by AVN. All patients had femoral head involvement, which was managed with hip replacement in six of them. All but one patient who developed AVN after allogeneic SCT suffered from chronic GVHD (cGVHD). Avascular necrosis occurred 1-4 months after exacerbation or progression of cGVHD. Cumulative dose of steroids was similar in both SCT groups (including steroids given pretransplant for the basic disease), whereas treatment duration was significantly longer in the allogeneic SCT group. Avascular necrosis was related to the decreased number of bone marrow CFU-F colonies in vitro, but not to BMD values. CONCLUSIONS. Avascular necrosis is a skeletal complication that occurs more often after allogeneic than after autologous SCT. Occurrence of AVN symptoms after clinical follow-p of cGVHD suggests that cGVHD requiring long-term steroid therapy is one of the main risk factors for AVN. Avascular necrosis may be facilitated by a severe deficit in the repopulating capacity of bone marrow stromal stem cells after SCT. © 2003 American Cancer Society.
Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: A single center experience and a review
| ▼ Phenotyping of murine models by preclinical imaging |
Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: A single center experience and a review
Other filter: ([btitle,keywords] "Avascular Necrosis" ...
Famulari ES, Navarro-tableros V, Herrera Sanchez MB, Bortolussi G, Gai M, Conti L, Silengo L, Tolosano E, Tetta C, Muro AF, Camussi G, Fagoonee S, Altruda F
* Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice (152 views)
Sci Rep (ISSN: 2045-2322linking, 2045-2322electronic), 2020 Jan 21; 10 (1 ): 887-887.
Impact Factor: 5.078
View Export to BibTeX Export to EndNote
Della Pepa R, Cerchione C, Pugliese N, Colicchio R, Salvatore P, Sirignano C, Soscia E, Pagano L, Sanguinetti M, Pane F, Picardi M
* Diagnostic-driven antifungal approach in neutropenic patients at high risk for chronic disseminated candidiasis: preliminary observations on the role of 1, 3-ß-D-glucan antigenemia and multiphasic contrast-enhanced computed tomography (215 views) (PDF 14 views)
Supportive Care Cancer (ISSN: 0941-4355), 2018 Jun; 26(6): 1691-1694.
Impact Factor: 2.676
View Export to BibTeX Export to EndNote
Filippi M, Boido M, Pasquino C, Garello F, Boffa C, Terreno E
* Successful in vivo MRI tracking of MSCs labeled with Gadoteridol in a Spinal Cord Injury experimental model (277 views)
Exp Neurol (ISSN: 0014-4886), 2016 Aug; 282: 66-77.
Impact Factor: 4.706
View Export to BibTeX Export to EndNote
De Chiara L, Fagoonee S, Ranghino A, Bruno S, Camussi G, Tolosano E, Silengo L, Altruda F
* Renal cells from spermatogonial germline stem cells protect against kidney injury (354 views)
J Am Soc Nephrol (ISSN: 1046-6673), 2014 Feb; 25(2): 316-328.
Impact Factor: 9.343
View Export to BibTeX Export to EndNote
Mariconda M, Soscia E, Sirignano C, Smeraglia F, Soldati A, Balato G
* Long-Term Clinical Results And Mri Changes After Tendon Ball Arthroplasty For Advanced Kienbock'S Disease (361 views) (PDF 9 views)
J Hand Surg Eur Vol (ISSN: 2043-6289, 0266-7681, 2043-6289electronic), 2013 Jun; 38(5): 508-514.
Impact Factor: 0.259
View Export to BibTeX Export to EndNote
Riccio A, Cubellis MV
* Gain of function in CDKN1C (508 views)
Nature Genetics (ISSN: 1061-4036), 2012 Jul; 44(7): 737-738.
Impact Factor: 35.209
View Export to BibTeX Export to EndNote
Lonardo E, Parish CL, Ponticelli S, Marasco D, Ribeiro D, Ruvo M, De Falco S, Arenas E, Minchiotti G
* A Small Synthetic Cripto Blocking Peptide Improves Neural Induction, Dopaminergic Differentiation, and Functional Integration of Mouse Embryonic Stem Cells in a Rat Model of Parkinson's Disease (774 views)
Stem Cells (ISSN: 1066-5099), 2010 Sep; 28(8): 1326-1337.
Impact Factor: 7.871
View Export to BibTeX Export to EndNote
Coppola G, Fortunato D, Auricchio G, Mainolfi C, Operto FF, Signoriello G, Pascotto A, Salvatore M
* Bone mineral density in children, adolescents, and young adults with epilepsy (391 views)
Epilepsia (ISSN: 1528-1167, 0013-9580), 2009 Sep; 50(9): 2140-2146.
Impact Factor: 4.052
View Export to BibTeX Export to EndNote
Picardi M, De Renzo A, Pane F, Nicolai E, Pacelli R, Salvatore M, Rotoli B
* Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans (396 views)
Leuk Lymphoma (ISSN: 1042-8194, 1026-8022linking), 2007 Sep; 48(9): 1721-1727.
Impact Factor: 1.512
View Export to BibTeX Export to EndNote
* Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice (152 views)
Sci Rep (ISSN: 2045-2322linking, 2045-2322electronic), 2020 Jan 21; 10 (1 ): 887-887.
Impact Factor: 5.078
View Export to BibTeX Export to EndNote
Della Pepa R, Cerchione C, Pugliese N, Colicchio R, Salvatore P, Sirignano C, Soscia E, Pagano L, Sanguinetti M, Pane F, Picardi M
* Diagnostic-driven antifungal approach in neutropenic patients at high risk for chronic disseminated candidiasis: preliminary observations on the role of 1, 3-ß-D-glucan antigenemia and multiphasic contrast-enhanced computed tomography (215 views) (PDF 14 views)
Supportive Care Cancer (ISSN: 0941-4355), 2018 Jun; 26(6): 1691-1694.
Impact Factor: 2.676
View Export to BibTeX Export to EndNote
Filippi M, Boido M, Pasquino C, Garello F, Boffa C, Terreno E
* Successful in vivo MRI tracking of MSCs labeled with Gadoteridol in a Spinal Cord Injury experimental model (277 views)
Exp Neurol (ISSN: 0014-4886), 2016 Aug; 282: 66-77.
Impact Factor: 4.706
View Export to BibTeX Export to EndNote
De Chiara L, Fagoonee S, Ranghino A, Bruno S, Camussi G, Tolosano E, Silengo L, Altruda F
* Renal cells from spermatogonial germline stem cells protect against kidney injury (354 views)
J Am Soc Nephrol (ISSN: 1046-6673), 2014 Feb; 25(2): 316-328.
Impact Factor: 9.343
View Export to BibTeX Export to EndNote
Mariconda M, Soscia E, Sirignano C, Smeraglia F, Soldati A, Balato G
* Long-Term Clinical Results And Mri Changes After Tendon Ball Arthroplasty For Advanced Kienbock'S Disease (361 views) (PDF 9 views)
J Hand Surg Eur Vol (ISSN: 2043-6289, 0266-7681, 2043-6289electronic), 2013 Jun; 38(5): 508-514.
Impact Factor: 0.259
View Export to BibTeX Export to EndNote
Riccio A, Cubellis MV
* Gain of function in CDKN1C (508 views)
Nature Genetics (ISSN: 1061-4036), 2012 Jul; 44(7): 737-738.
Impact Factor: 35.209
View Export to BibTeX Export to EndNote
Lonardo E, Parish CL, Ponticelli S, Marasco D, Ribeiro D, Ruvo M, De Falco S, Arenas E, Minchiotti G
* A Small Synthetic Cripto Blocking Peptide Improves Neural Induction, Dopaminergic Differentiation, and Functional Integration of Mouse Embryonic Stem Cells in a Rat Model of Parkinson's Disease (774 views)
Stem Cells (ISSN: 1066-5099), 2010 Sep; 28(8): 1326-1337.
Impact Factor: 7.871
View Export to BibTeX Export to EndNote
Coppola G, Fortunato D, Auricchio G, Mainolfi C, Operto FF, Signoriello G, Pascotto A, Salvatore M
* Bone mineral density in children, adolescents, and young adults with epilepsy (391 views)
Epilepsia (ISSN: 1528-1167, 0013-9580), 2009 Sep; 50(9): 2140-2146.
Impact Factor: 4.052
View Export to BibTeX Export to EndNote
Picardi M, De Renzo A, Pane F, Nicolai E, Pacelli R, Salvatore M, Rotoli B
* Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans (396 views)
Leuk Lymphoma (ISSN: 1042-8194, 1026-8022linking), 2007 Sep; 48(9): 1721-1727.
Impact Factor: 1.512
View Export to BibTeX Export to EndNote
9 Records (8 excluding Abstracts).
Total impact factor: 70.706 (61.363 excluding Abstracts).
Total 5 year impact factor: 68.492 (58.871 excluding Abstracts).
Total impact factor: 70.706 (61.363 excluding Abstracts).
Total 5 year impact factor: 68.492 (58.871 excluding Abstracts).
277 views. Last view on Tuesday 07 March 2023, 20:38:20
ibb.cnr.it
